de los Pinos Elisabet — SEC Form 4 filings
SEC reporting owner CIK 1889633. 13 Form 4 filings on record with FilingPulse; latest filed 2026-03-03.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-01-24 to 2026-03-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 8 legs across 8 filings — 159,846 shares, $1,180,774 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
- Largest priced transaction: sale of 24,992 shares @ $12.04 ($300,839) in Aura Biosciences, Inc., filed 2024-10-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Aura Biosciences, Inc. (AURA) | See Remarks, Director | 13 | — | 8 legs · 159,846 sh · $1,180,774 | 13 |
Form 4 filings — de los Pinos Elisabet
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-03 | 4 | Aura Biosciences, Inc. (AURA) | Grant/award (A): 166,000 @ $0 · Grant/award (A): 249,000 (derivative) @ $0 | EDGAR |
| 2026-02-17 | 4 | Aura Biosciences, Inc. (AURA) | Sale (S): 47,648 @ $5.06 | EDGAR |
| 2026-01-20 | 4 | Aura Biosciences, Inc. (AURA) | Sale (S): 16,928 @ $4.86 | EDGAR |
| 2025-10-29 | 4 | Aura Biosciences, Inc. (AURA) | Sale (S): 9,049 @ $6.35 | EDGAR |
| 2025-06-04 | 4 | Aura Biosciences, Inc. (AURA) | Option exercise (M): 10,948 @ $5.07 · Tax withholding (F): 9,948 @ $6.16 · Option exercise (M): 10,948 (derivative) @ $0 | EDGAR |
| 2025-02-18 | 4 | Aura Biosciences, Inc. (AURA) | Sale (S): 20,221 @ $7.75 | EDGAR |
| 2025-02-04 | 4 | Aura Biosciences, Inc. (AURA) | Grant/award (A): 194,320 @ $0 · Grant/award (A): 255,680 (derivative) @ $0 | EDGAR |
| 2025-01-21 | 4 | Aura Biosciences, Inc. (AURA) | Sale (S): 15,955 @ $7.67 | EDGAR |
| 2024-10-29 | 4 | Aura Biosciences, Inc. (AURA) | Sale (S): 9,200 @ $10.74 | EDGAR |
| 2024-10-18 | 4 | Aura Biosciences, Inc. (AURA) | Option exercise (M): 24,992 @ $2.74 · Sale (S): 24,992 @ $12.04 · Option exercise (M): 24,992 (derivative) @ $0 | EDGAR |
| 2024-10-01 | 4 | Aura Biosciences, Inc. (AURA) | Option exercise (M): 5,474 @ $5.76 · Option exercise (M): 5,474 (derivative) @ $0 | EDGAR |
| 2024-02-02 | 4 | Aura Biosciences, Inc. (AURA) | Grant/award (A): 162,935 @ $0 · Grant/award (A): 237,065 (derivative) @ $0 | EDGAR |
| 2024-01-24 | 4 | Aura Biosciences, Inc. (AURA) | Sale (S): 15,853 @ $7.64 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1889633 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →